|
注册号: Registration number: |
ChiCTR2500115740 |
|
最近更新日期: Date of Last Refreshed on: |
2025-12-30 16:38:10 |
|
注册时间: Date of Registration: |
2025-12-30 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
保定地区儿童社区获得性耐甲氧西林金黄色葡萄球菌耐药性与基因特征研究 |
|
Public title: |
Study on the Antimicrobial Resistance and Genetic Characteristics of Methicillin-Resistant Staphylococcus aureus among Children in the Baoding Area |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
保定地区儿童社区获得性耐甲氧西林金黄色葡萄球菌耐药性与基因特征研究 |
|
Scientific title: |
Study on the Antimicrobial Resistance and Genetic Characteristics of Methicillin-Resistant Staphylococcus aureus among Children in the Baoding Area |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
邸瑞华 |
研究负责人: |
邸瑞华 |
|
Applicant: |
Di Ruihua |
Study leader: |
Di Ruihua |
|
申请注册联系人电话: Applicant telephone: |
+86 173 3021 5273 |
研究负责人电话:
Study leader's |
+86 312 337 7683 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
847986554@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
847986554@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
恒祥北大街3399号 |
研究负责人通讯地址: |
恒祥北大街3399号 |
|
Applicant address: |
No. 3399 Hengxiang North Street, Lianchi District, Baoding City, Hebei Province |
Study leader's address: |
No. 3399 Hengxiang North Street, Lianchi District, Baoding City, Hebei Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
首都医科大学附属北京儿童医院保定医院 |
||
|
Applicant's institution: |
Baoding Hospital of Beijing Children's Hospital, Capital Medical University |
||
|
研究负责人所在单位: |
首都医科大学附属北京儿童医院保定医院 |
||
|
Affiliation of the Leader: |
Beijing Children's Hospital Affiliated to Capital Medical University Baoding Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2025(年)伦审[科]第(58)号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
首都医科大学附属北京儿童医院保定医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Baoding Hospital of Beijing Children's Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-11-04 00:00:00 | ||
|
伦理委员会联系人: |
张瑜 |
||
|
Contact Name of the ethic committee: |
Zhang Yu |
||
|
伦理委员会联系地址: |
恒祥北大街3399号 |
||
|
Contact Address of the ethic committee: |
No. 3399 Hengxiang North Street, Lianchi District, Baoding City, Hebei Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 312 337 7597 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
kejiaoke3377828@126.com |
|
研究实施负责(组长)单位: |
首都医科大学附属北京儿童医院保定医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Beijing Children's Hospital Affiliated to Capital Medical University Baoding Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
恒祥北大街3399号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 3399 Hengxiang North Street, Lianchi District, Baoding City, Hebei Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
2025年保定市科技计划项目(第二批) |
||||||||||||||||||||||
|
Source(s) of funding: |
Baoding City Science and Technology Project Plan (Batch 2), 2025. |
||||||||||||||||||||||
|
研究疾病: |
皮肤及软组织感染:皮肤出现红肿、疼痛的脓疱、蜂窝织炎,形成脓肿,可伴有波动感、破溃流脓,严重时出现坏死性筋膜炎,表现为皮肤发黑、剧痛、全身高热;肺部感染:突发高热、寒战、咳嗽,咳黄脓痰或血痰,出现胸闷、呼吸困难,甚至呼吸衰竭,胸部影像学可见多发肺部浸润影或脓肿;中枢神经系统感染:剧烈头痛、呕吐、颈项强直,高热、意识模糊、嗜睡甚至昏迷,可出现癫痫发作;血流感染:持续高热、寒战,体温可超过39℃,头晕 |
||||||||||||||||||||||
|
Target disease: |
Skin and soft tissue infections: The skin exhibits redness, swelling, painful pustules, and cellulitis, which can lead to the formation of abscesses. There may be a feeling of fluctuation, rupture, and pus discharge. In severe cases, necrotizing fasciitis can occur, characterized by blackening of the skin, severe pain, and high fever throughout the body. Pulmonary infections: Sudden high fever, ch |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
横断面 |
||||||||||||||||||||||
|
Study design: |
Cross-sectional |
||||||||||||||||||||||
|
研究目的: |
项目拟揭示保定地区儿童CA-MRSA的主要流行株、耐药基因与毒力因子特征,为临床提供精准用药依据,并为制定区域化防控策略提供科学数据支持。项目研究结果将填补该地区儿童CA-MRSA研究的空白,对降低儿童感染率、推动区域内儿童感染性疾病防控具有重要意义。 |
||||||||||||||||||||||
|
Objectives of Study: |
The project aims to reveal the main circulating strains, drug-resistant genes, and virulence factors of CA-MRSA among children in the Baoding region. This will provide precise evidence for clinical treatment and support the development of region-specific prevention and control strategies. The findings of the project will fill the gap in research on CA-MRSA among children in this region, which is of great significance in reducing child infection rates and promoting the prevention and control of infectious diseases among children within the region. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
排除有多次住院史的患儿 |
||||||||||||||||||||||
|
Exclusion criteria: |
Exclude children with a history of multiple hospitalizations |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-10-01 00:00:00至 To 2028-10-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2026-01-01 00:00:00 至 To 2026-05-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
None |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
NO |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
本研究通过标准化病例记录表采集患儿年龄、性别、临床诊断等临床资料,收集分离的金黄色葡萄球菌菌株并于-70℃保存,同步记录药敏实验、DNA提取浓度、全基因组测序等实验数据,采用电子数据采集系统(EDC)集中管理所有数据,设置权限并定期备份,确保数据完整、准确、安全。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
This study collected clinical data on the age, gender, and clinical diagnoses of the patients using a standardized case report form (CRF). Isolated strains of Staphylococcus aureus were collected and stored at –70°C. Simultaneously, experimental data such as drug sensitivity tests, DNA extraction concentrations, and whole-genome sequencing were recorded. All data were centrally managed using an electronic data capture system (EDC), with access permissions and regular backups implemented to ensure data integrity, accuracy, and security. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |